Plus Therapeutics Inc (NASDAQ:PSTV)’s traded shares stood at 6.18 million during the last session, with the company’s beta value hitting 0.64. At the close of trading, the stock’s price was $0.31, to imply a decrease of -0.94% or $0.0 in intraday trading. The PSTV share’s 52-week high remains $2.31, putting it -645.16% down since that peak but still an impressive 48.39% since price per share fell to its 52-week low of $0.16. The company has a valuation of $15.66M, with an average of 116.03 million shares in intraday trading volume over the past 10 days and average of 24.36 million shares over the past 3 months.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
After registering a -0.94% downside in the last session, Plus Therapeutics Inc (PSTV) has traded red over the past five days. The 5-day price performance for the stock is -2.48%, and -16.45% over 30 days. With these gigs, the year-to-date price performance is -79.10%. Short interest in Plus Therapeutics Inc (NASDAQ:PSTV) saw shorts transact 1.17 million shares and set a 0.1 days time to cover.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 46.51% for the past 5-year period. While 2025 is set for a 55.00% return in earnings, projections for the next 5 years are at 53.45% annually.
PSTV Dividends
Plus Therapeutics Inc has its next earnings report out on 2025-May-30. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Plus Therapeutics Inc (NASDAQ:PSTV)’s Major holders
Plus Therapeutics Inc insiders hold 2.02% of total outstanding shares, with institutional holders owning 2.50% of the shares at 2.55% float percentage. In total, 2.50% institutions holds shares in the company, led by AIGH CAPITAL MANAGEMENT LLC. As of 2024-06-30, the company held over 0.57 million shares (or 8.7478% of shares), all amounting to roughly $0.84 million.
The next major institution holding the largest number of shares is GEODE CAPITAL MANAGEMENT, LLC with 46648.0 shares, or about 0.7176% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $68572.0.
We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Plus Therapeutics Inc (PSTV) shares. Going by data provided on Apr 30, 2025 , Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 34.71 shares. This is just over 0.07% of the total shares, with a market valuation of $10663.0. Data from the same date shows that the other fund manager holds a little less at 32.54, or 0.06% of the shares, all valued at about 9996.0.
